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Propionibacterium acnes (PA) is a gram-positive anaerobic bacterium
implicated as a putative etiologic agent of sarcoidosis. To character-
ize the pulmonary immune response to PA, C57BL/6 and BALB/c
mice were intraperitoneally sensitized and intratracheally chal-
lenged with heat-killed bacteria. C57BL/6 mice challenged with PA
developed a cellular immune response characterized by elevations
in Th1 cytokines/chemokines, increased numbers of lymphocytes
and macrophages in lung lavage fluid, and peribronchovascular
granulomatous inflammation composed of T- and B-lymphocytes
and epithelioid histiocytes. T-lymphocytes in the lung lavage fluid
showed a marked CD4 cell predominance. In contrast, C57BL/6
mice challenged with Staphylococcus epidermidis (SE), another gram-
positive commensal of human skin, and BALB/c mice challenged with
PA, showed only a modest induction of Th1 cytokines, less pulmo-
nary inflammation, and no granulomatous changes in the lung.
Enhancement of Toll-like receptor expression was seen in PA-
exposed C57BL/6 mice within 24 h after exposure, suggesting that
induction of innate immunity by PA contributes to the robust, polar-
ized Th1 immune response elicited by this bacterium. These findings
suggest that PA-induced pulmonary inflammation may be a useful
model for testing the contributions of both bacterial and host fac-
tors in the development, maintenance, and resolution of granulo-
matous inflammation in the lung.
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Sarcoidosis is a systemic disease of unknown cause characterized
by noncaseating granulomata in organs and tissues. The disease
most frequently involves the lung and thoracic lymph nodes,
but other organs, including the liver, spleen, skin, and eyes, are
commonly involved. Pathologically, the granulomas of sarcoidosis
are composed of a central core of macrophages and dendritic cells.
Both surrounding and admixed with these antigen-presenting cells
(APCs) are T- and to a lesser extent B-lymphocytes (1). Ultra-
structural examination of the sarcoid granuloma has shown an
intimate association and interdigitation of the cell walls of lym-
phocytes and APCs, suggesting cross talk between these cells
(2). Oligoclonal expansion of distinct T-cell subsets has been
reported in patients with sarcoidosis (3, 4). Based on these obser-
vations, the pathogenesis of sarcoidosis is believed to be antigen-
driven. Despite the collective data suggesting an antigen-induced
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immune response, the definitive antigen or antigens of sarcoido-
sis have remained elusive. Many studies have suggested putative
infectious agents, but the data from these investigations have
been insufficiently robust to unequivocally confirm that a partic-
ular agent is causative (5).
In Japan, a series of microbiological and molecular investiga-
tions have suggested that Propionibacteria spp. may be etiologi-
cally linked to sarcoidosis (6–10). Propionibacteria are gram-
positive anaerobic bacteria that are well recognized as part of
the normal microbiota of the human skin (11). Recently, propio-
nibacteria have been cultured from peripheral lung tissue and
mediastinal lymph nodes from patients without sarcoidosis,
suggesting that they may be commensal in the lung as well (12).
In human skin, an immune response is not generally mounted
against resident Propionibacteria spp. or other flora such as
Staphylococcus epidermidis (SE). However, in acne, the most
common disease affecting the skin, an inflammatory response
to Propionibacterium acnes (PA) is believed to contribute to
disease pathogenesis (13). Thus, an exaggerated immune re-
sponse against a bacterium present in organs frequently affected
by sarcoidosis, such as the lung and skin, is a plausible theory
of pathogenesis.
In the 1970s Corynebacterium parvum, genetically identical to
and now known as PA, was tested in mice as an immunostimulant
adjuvant therapy for cancer. In addition to anti-tumor effects,
mice inoculated intravenously with heat-killed PA developed
hepatosplenomegaly with granulomatous inflammation in the
livers, spleens, and lymph nodes, establishing the capacity of
this organism to induce granulomatous inflammation. Peripheral
lymphopenia, increased antibody response, and increased resis-
tance to infection were additional features observed after intra-
venous challenge with these anaerobic coryneform bacteria (14).
Interestingly, all of these features have been reported in humans
with sarcoidosis (15).
More recently PA has been used as a priming agent for LPS-
induced acute liver injury. In this model, PA priming before
LPS challenge profoundly enhances the degree of hepatic injury
after LPS exposure (16). This liver injury model has been exten-
sively characterized, including the priming phase by intravenous
PA, which results in granuloma development in the murine liver
(17–19). In contrast, little is known about the pulmonary immune
response to PA. Given the increasing interest in this organism as
a putative etiologic agent of sarcoidosis, we have investigated the
pulmonary immune response to PA in C57BL/6 and BALB/c mice.
MATERIALS AND METHODS
Mice
Pathogen-free C57BL/6 and BALB/c mice were purchased from the
Jackson Laboratory (Bar Harbor, ME), bred in our animal facility, and
used between 3 and 6 mo of age. Exposed and control mice were housed
in filter-top cages and kept in a negative-pressure, ventilated cubicle
in the Keck Animal Models Facility at the University of North Carolina,
Chapel Hill. All animal experiments complied with the Institutional
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Animal Care and Use Committee guidelines of University of North
Carolina as well as the National Institutes of Health Guide for the Care
and Use of Laboratory Animals.
Bacteria
PA cultures (ATCC #6919) were grown on sheep blood agar in an
anaerobic chamber (COY Laboratory Products, Inc., Grass Lake, MI)
at 37C in the microbiology laboratory at UNC Hospitals. A control
gram-positive bacterium, SE (ATCC #12228), was also grown on sheep
blood agar at 37C. After 48 h, the cultures were examined for growth
and used for experiments when colonies became confluent. The identity
of the PA was verified by colony morphology, indole positivity, and
Gram staining.
Inoculation of Mice with Bacteria
PA colonies were isolated from blood agar plates and suspended in
PBS. The bacteria were heat-killed by autoclaving at 121C and then
intraperitoneally injected (0.5 mg: 0.25ml of the 2mg/ml suspension)
into mice. Two weeks after intraperitoneal injection, PA-sensitized mice
were challenged with heat-killed PA (0.5 mg: 0.05 ml of 10 mg/ml
suspension) intratracheally. C57BL/6 and BALB/c mice sensitized and
challenged with PBS (PBS/PBS) were used as controls. To determine
the specific impact of sensitization alone as well as challenge alone,
some C57BL/6 mice were either sensitized to PA but not challenged
(intraperitoneal PA/intratracheal PBS), or nonsensitized but challenged
(intraperitoneal PBS/intratracheal PA). As an additional control to
determine whether the observed immune response was specific to PA
or common to gram-positive bacteria, some mice were intraperitoneally
sensitized with heat-killed SE and subsequently challenged with heat-
killed SE using a dosing scheme identical to that described above for
PA. The total numbers of animals examined in each of these groups
are detailed in Tables E1 and E2 in the online supplement. Mice were
killed on Days 1, 3, 5, 7, 14, 21, 28, 35, 42, and 54 after challenge by
an overdose of pentobarbital sodium (150 mg/kg), and organs and cells
were harvested for histologic, cytokine, and RNA analysis.
Whole Lung Lavage
The trachea was exposed and cannulated with a 19-gauge blunt-tipped
cannula and the lungs were lavaged with 1 ml of sterile Hank’s Balanced
Saline Solution (HBSS). After removal the lavage fluid was immediately
placed on ice and centrifuged at 1,500 rpm for 5 min at 4C. After
centrifugation, the supernatant was removed and stored at 80C until
further use for analysis of cytokines. The cell pellet was resuspended
in 0.5 ml of cold HBSS for determination of total and differential cell
counts. Total cells were counted with a hemocytometer. Cells were
cytospun onto glass slides using a Cytospin 3 centrifuge (Shandon,
Pittsburgh, PA) at 1,000 rpm for 6 min and stained with a Hema 3 stain
(Fisher Scientific, Hampton, NH) for determination of cellular differentials.
Flow Cytometry
Lung lavage cells from mice sensitized and intratracheally challenged
with PA and SE were examined 7 and 21 d after challenge. Lavage
fluid from three mice in each group were pooled, centrifuged, and
resuspended in FACs Wash (HBSS, 2% FBS; Invitrogen, Grand Island,
NY) containing FC Block (FcIII/II) (0.25 l/ml) at a concentration of
1  105 cells/100 l. After incubation for 15 min, cells were aliquoted
into 96-well plates at a concentration of 100,000 cells/well. Five microli-
ters of diluted FITC-CD4 rat anti-mouse L3T4 clone (RM4-5) and
PerCP-CD8a rat anti-mouse Ly-2 clone (55-6.7) (BD Biosciences, San
Diego, CA) were added to each well. After 5 min incubation, cells
were washed three times with FACs Wash, resuspended in FACs Fix
(HBSS, 10% neutral buffered formalin [NBF]), and stored at 4C until
FACs analysis.
Lung Histology
After whole lung lavage, the lungs were inflated with 10% NBF at
20 cm H2O. Lungs and heart were removed en bloc and immersed in
10% NBF for 24 h before paraffin embedding. All lobes of the lung
were dehydrated, paraffin-embedded, and one 5-m section was cut
across each lobe. Sections were stained with hematoxylin and eosin
(H&E) for histologic evaluation.
Immunohistochemistry
Tissue sections were cut, floated on a protein-free water bath, mounted
on saline-treated slides (Fisher, Raleigh, NC), and air-dried overnight.
The slides were heat-fixed at 60C in a slide dryer (Shandon Lipshaw,
Pittsburgh, PA) for 10 min and cooled to room temperature. Sections
were then deparaffinized and hydrated to 95% alcohol (xylene for
10 min, absolute alcohol for 5 min, and 95% alcohol for 5 min). Endoge-
nous peroxidase activity was blocked with 0.6% H2O2 in absolute metha-
nol for 8 min. Slides were rinsed in 95% alcohol for 2 min, placed in
deionized H2O, and washed in PBS. After treatment with Cyto Q
Background Buster (Innovex Biosciences, Richmond, CA) for 10 min,
slides were incubated with the primary antibodies against CD68 (Dako,
Carpinteria, CA), CD4 (Santa Cruz Biotechnology, Santa Cruz, CA ),
and CD45R/B220 (BD Pharmingen, San Diego, CA) diluted in 1%
BSA for 45 min at 37 C in PBS at a dilution of 1:25. Slides were
incubated with biotinylated linking antibody from Stat-Q Staining
System (Innovex Biosciences) for 10 min at room temperature, washed
with PBS, and peroxidase enzyme label from Stat-Q Staining System
(Innovex Biosciences) applied. After incubation for 10 min at room
temperature and washes with PBS, tissue sections were developed with
3,3 diaminobenzidine-tetrahydrochloride for 3 min at room tempera-
ture. Sections were counterstained with hematoxylin or methylene
green, dehydrated through alcohols, cleared in xylene, and coverslipped
using a permanent mounting media.
Lung Homogenates
Lungs were snap-frozen in liquid nitrogen and stored at 80C until
homogenization. Lungs were homogenized in lysis buffer (300 mM
NaCl, 15 mM Tris, 4 mM MgCl2, 0.1% Triton-X 100, 5 g/ml leupeptin,
5 g/ml aprotinin, pH 7.4 and filter sterilized) and centrifuged at
1,500  g for 15 min at 4C. Supernatant was removed, mixed, aliquoted,
and stored at 80C until use.
ELISA
The concentrations of TNF-	, IFN-, IL-4, IL-12 p40, IL-12p70, IL-13,
and monocyte chemoattractant protein-1 (MCP-1) were measured by
ELISA, according to the manufacturer’s instructions (R&D Systems
Inc., Minneapolis, MN).
RNA Analysis by Quantitative Real-Time PCR
Lungs and livers were removed and snap-frozen in liquid nitrogen, then
stored at 80C. Total RNA was extracted using RNA-bee (Tel-Test,
Friendswood, TX) according to the manufacturer’s instructions. RNA
was then treated with RQ1 DNase (Promega, Madison, WI) and
reverse-transcribed with the High Capacity cDNA Archive Kit (Applied
Biosystems, Foster City, CA). Expression levels TNF-	, IFN-,
IL-12p35, MCP-1, angiotensin-converting enzyme (ACE), Toll-like
receptor (TLR) 1, TLR2, TLR4, TLR5, and TLR9 were determined
by Quantitative Real-Time PCR on the ABI 7900HT Real-Time PCR
System (Applied Biosystems). Taqman Universal PCR Master Mix
and the following primers and probes for PCR were purchased from
Applied Biosystems: Mouse 
-actin Endogenous Control (4352341E),
Taqman Gene Expression Assays for TNF-	 (Mm00443258_m1),
IFN- (Mm0080178_m1), IL-12p35 (Mm00434165_m1), MCP-1
(Mm00441242_m1), ACE (Mm00802048_m1), TLR1 (Mm00446095_m1),
TLR2 (Mm00442346_m1), TLR4 (Mm00445274_m1), TLR5
(Mm00546288_s1), and TLR9 (Mm00446193_m1). Relative mRNA ex-
pression, normalized to the mouse 
-actin gene, was calculated by the
comparative Ct method, and compared to RNA expression in the lungs
of control mice (PBS/PBS) not exposed to bacteria.
Statistical Analysis
All data are presented as means  SE. Statistical significance was
assessed by the two-tailed, unpaired Student’s t test.
RESULTS
Lung Histopathology after Sensitization and
Challenge with PA
Lung histology was evaluated in sensitized C57BL/6 mice 1, 3,
5, 7, 14, 21, 28, 35, 42, and 54 d after intratracheal challenge
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Figure 1. Lung histopathol-
ogy 7 d after intratracheal
challenge with PA and SE.
C57BL/6 were intraperitone-
ally sensitized and challenged
2 wk later with heat-killed
PA (A, B, C ). Lung histopa-
thology was compared with
C57BL/6 mice sensitized/
challenged with SE (D, E, F )
and BALB/c mice sensitized/
challenged with PA (G, H, I ).
Representative H&E-stained
sections from each group are
shown at magnifications of
2 (A, D, G ), 10 (B, E, H ),
and 60 (C, F, I ).
with heat-killed PA. Twenty-four hours after intratracheal chal-
lenge, a peribronchovascular (PBV) neutrophilic infiltrate and
patchy acute pneumonia was observed (Figure E1 in the online
supplement). On Day 3 a mixed neutrophilic and lymphocytic
PBV infiltrate was seen, with areas of epithelioid histiocytes
and loose granulomas (Figure E2). By Day 5 a lymphocyte-
predominant PBV infiltrate with admixed histiocytes was present
along with rare loose granulomata (Figure E3). Peak inflamma-
tion was observed on Day 7 after intratracheal challenge with
PA, composed of lymphohistiocytic PBV infiltrates around
most airways and vessels (Figures 1A and E4). Loose granulo-
mata were present in the PBV stroma and lung parenchyma
(Figures 1B, 1C, and E4). By Day 14, PA-exposed mice showed
variably dense lymphohistiocytic PBV infiltrates, which were
less prominent than those seen 7 d after exposure. Granulomata
were observed in some sections but were infrequent (Figure E5).
On Day 21, PA-exposed mice showed focal lymphoplasmacytic
infiltrates without granulomata (Figure E6). Subsequent time
points showed mild PBV lymphocytic infiltrates consistent with
bronchus-associated lymphoid tissue (BALT) aggregates and
only rare PBV granulomata (Figure E7).
Next, we investigated whether this inflammatory response in
the lung was unique to PA or whether it was a general response to
gram-positive bacteria. We chose to test SE, another commensal
gram-positive organism of human skin. Mice were intraperitone-
ally sensitized with SE and intratracheally challenged 2 wk later
with the same organism. Lung histology was evaluated at the
same time points as the PA-sensitized and -challenged mice
described above. Twenty-four hours after intratracheal inocula-
tion with SE, PBV acute inflammation and patchy acute pneumo-
nia was observed and was similar in magnitude to PA-exposed
mice (Figure E1). A mixed neutrophilic and lymphocytic PBV
inflammation was seen 3 d after exposure (Figure E2). These
infiltrates included rare eosinophils without histiocytes or granu-
lomata. On Day 5, a lymphocyte-predominant PBV infiltrate
was present with some admixed histiocytes. Infiltrates were less
dense than those observed in PA-exposed mice (Figure E3).
Seven days after exposure a lymphocytic PBV infiltrate was seen.
Admixed histiocytes were rare in SE-exposed mice (Figures
1D–1F), but frequent in the PA-exposed animals (Figures 1A–
1C). On Day 14, SE-exposed mice showed only focal scant PBV
lymphocytic infiltrates with rare histiocytes, and no granuloma
formation (Figure E5). On Day 21 SE-exposed mice showed no
significant inflammation, with rare single plasma cells noted in
the PBV stroma (Figure E6). Subsequent time points showed
mild PBV lymphocytic infiltrates consistent with BALT aggre-
gates, as was observed in PA-exposed mice. Granulomas were
not observed in SE-treated animals. Overall, PA-exposed mice
showed a denser PBV infiltrate than SE mice at each time point,
and a higher incidence of granulomata. The inflammation in
both PA and SE mice peaked in intensity at Day 7, and decayed
back to normal by Day 21 in SE mice and by Day 42 in PA
mice.
Next, we evaluated lung morphology in BALB/c mice sensi-
tized and intratracheal challenged with PA to determine whether
background strain was important to lung phenotype. Similar to
C57BL/6 mice challenged with PA, a PBV and alveolar neutro-
philic infiltrate was observed 1 day post intratracheal challenge.
By Day 3, PBV mixed acute and chronic inflammation was ob-
served. On Days 5 and 7 after PA challenge, only PBV chronic
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inflammation was observed. In contrast to PA-challenged
C57BL/6 mice, no significant histiocytic component was noted
in these infiltrates, and no granuloma formation was observed
(Figures 1G–1I). These histopathologic findings suggest that PA
possesses unique qualities that render the organism capable of
eliciting granulomatous inflammation in the murine lung, and
that the capacity to mount a granulomatous response to PA is
also dependent upon the genetic characteristics of the mouse.
Inflammatory Cells in Lung Lavage Fluid
Next, we examined the inflammatory cell composition of the
lung lavage fluid at each time-point evaluated histologically.
Figure 2A shows total cells in the lung lavage fluid at each time
point after intratracheal challenge with PA or SE. An increase
in total cells was observed in response to both PA and SE in
C57BL/6 mice, 1 and 3 d after exposure. Total cells remained
elevated in the PA group through Day 21. In contrast, cell counts
in SE-exposed mice returned to normal by Day 5. Both organ-
isms produced an acute rise in neutrophils that persisted through
Day 7 in the PA group and through Day 5 in the SE group;
however, neutrophil numbers were significantly greater in PA-
exposed mice on Days 5 and 7 (Figure 2B). A marked lymphocy-
tosis developed in PA-exposed mice by Day 5 and persisted
through Day 21 (Figure 2C). A trend toward increased numbers
of lymphocytes was still observed up to 28 d after challenge
(2.6  1  104 versus 1.85  1.1  104 cells/ml, P  0.09). Only
a modest increase in lymphocytes was observed in the SE group.
The number of macrophages was also increased in the lung
lavage fluid of PA-challenged mice on Days 5, 7, and 14 after
intratracheal challenge. No such increase in macrophage number
was seen in any of the SE-challenged mice.
BALB/c mice were examined through 14 d after intratracheal
challenge with PA. While total cells increased in the lavage fluid
of BALB/c mice, numbers were significantly lower than those
in similarly treated C57BL/6 animals (Figure 2A). The inflam-
matory response in BALB/c mice was characterized by an early
rise and rapid decline in neutrophils, followed by an increase
in lymphocytes (Figures 2B–2D). However, the magnitude and
duration of neutrophilia and lymphocytosis was significantly
lower than that observed in C57BL/6 mice exposed to PA.
Next we were interested in determining whether PA could
elicit a similar immune response in the lungs of C57BL/6 mice
without prior sensitization. Total cells and differentials were
examined 7 and 14 days after intratracheal exposure to PA or
PBS, in groups with and without sensitization. As shown in
Figure 3A, a significant increase in total cells at Day 7 was only
observed in mice sensitized and challenged intratracheally with
PA, and was due to increased numbers of lymphocytes, macro-
phages, and neutrophils. A modest but statistically significant
increase in lymphocytes was seen on Day 7 in PA-challenged mice
that were not sensitized (2.1  0.25  104 versus 0.68  0.14 
104 cells/ml, P  0.02); however, this response was significantly
lower than that seen in PA-exposed mice receiving sensitization
(25.4  7.2  104 versus 2.1  0.25  104 cells/ml, P  0.02).
By Day 14, neutrophilia had resolved but macrophages and
lymphocytes remained significantly elevated in mice sensitized
and intratracheally challenged with PA, but not in nonsensitized
mice (Figure 3B). These results show that sensitization signifi-
cantly enhances the recruitment of leukocytes to the lung after
PA challenge.
Characterization of the Lymphohistiocytic Inflammation in
PA-Exposed Mice
Robust increases in lung lavage fluid lymphocytes and a corre-
sponding aggregation of epithelioid histiocytes and lymphocytes
Figure 2. Time course and characterization of leukocytes in the lung
lavage fluid after sensitization and challenge with PA. PA sensitized/
challenged C57BL/6 mice (solid bars) are compared with SE sensitized/
challenged C57BL/6 mice (shaded bars) and PA sensitized/challenged
BALB/c mice (open bars). Mice treated with intraperitoneal PBS and
intratracheal PBS were used as controls (striped bars). (A ) Total cells.
(B ) Neutrophils. (C ) Lymphocytes. (D ) Macrophages. Data are represen-
tative of three independent experiments and are expressed as mean
cell number  SEM. *P  0.05 versus control mice of the same genetic
background, P  0.05 versus PA-exposed C57BL/6 mice (n  3–6
mice per group).
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Figure 3. Effect of sensitization on leukocyte recruitment to the lung
of C57BL/6 mice. Seven (A ) and 14 (B ) d after intratracheal challenge,
mice sensitized and challenged with PA (black bars) were compared
with mice intratracheally challenged but not sensitized (dark gray bars),
mice sensitized but not challenged (light gray bars), and control mice
that were neither sensitized nor challenged with PA (open bars). Data
represent mean cell number recovered from each animal,  SEM.
*P  0.05 versus intraperitoneal PBS/intratracheal PBS control mice,
P  0.05 versus intraperitoneal PBS/intratracheal PA control mice
(n  3–4 mice per group).
into loose granulomata in C57BL/6 mice sensitized and intratra-
cheally challenged with PA suggested that PA-induced lung in-
flammation should be further investigated to determine its full
potential as an animal model for sarcoidosis. To further charac-
terize the cell populations infiltrating the lung after PA exposure,
we performed immunohistochemistry on lung slices 7 d after
exposure. As shown in Figure 4, a mixed population of CD68
(tissue macrophages and dendritic cells), CD4 T lymphocytes,
and CD45/B220 (B cells) are present in the peribronchovascu-
lar infiltrates. Serially cut control sections treated with the sec-
ondary antibody only showed no staining. To further character-
ize the T cell population, flow cytometry was performed on lung
lavage fluid lymphocytes. As described above, more lymphocytes
were recovered from the lungs of PA-challenged than from
SE-challenged animals as determined by cellular differentials of
cytospun lavage fluid. Forward and side scatter properties by
flow cytometry confirmed this visual observation, showing 20%
and 29% of the total lavage fluid cells in the lymphocyte gate
in PA-exposed mice on Days 7 and 21, respectively. In contrast,
only 11% (Day 7) and 4% (Day 21) of total lavage fluid cells
in the SE-exposed group were lymphocytes. The majority of the
T-lymphocytes from PA-exposed mice expressed CD4 rather
than CD8, with a CD4/CD8 ratio of 2:1 on Day 7 and 10:1 on
Day 21 (Figure E8). These results show that PA results in both
B and T cell recruitment to the murine lung, and that the vast
majority of T cells are of the CD4 T-helper subtype.
Proinflammatory Cytokines and Chemokines in
PA-Exposed Mice
TNF-	, IFN-, and IL-12 are three cytokines believed to be
critical for the development of granulomatous inflammation in
Figure 4. Cell types present in peribronchovascular infiltrates of PA-
exposed mice. Immunohistochemistry was performed on sections from
formalin-fixed, paraffin-embedded lung from mice 7 d after intratra-
cheal challenge with PA using antibodies against CD68 (A ), CD4 (B ),
and CD45/B220 (C ). Biotinylated secondary antibody was used with
Streptravidin-HRP/DAB detection system with hematoxylin (A, B ) and
methylene green (C ) counterstains.
sarcoidosis. After intratracheal inoculation with PA, we found
increases in mRNA expression of TNF-	, IFN-, and IL-12p35,
the rate-limiting subunit of the IL-12p70 complex (Figure E9).
To determine the functional significance of these changes in gene
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expression at the protein level, these cytokines were measured in
the lung lavage fluid and whole lung homogenates from PA-
and SE-exposed C57BL/6 mice as well as in PA-exposed BALB/c
mice by ELISA. Twenty-four hours after intratracheal challenge,
TNF-	 levels increased in lung lavage fluid from all mice and
was greater in SE-challenged animals (2,565  209 versus 1,421 
263 pg/ml, P  0.01; Figure 5A). However, on Days 3, 5, and 7
after challenge, TNF-	 levels were significantly higher in the
PA-challenged C57BL/6 group relative to the SE group (272 
91 versus 14  14 pg/ml, P  0.04; 128  18 versus 0.8 
0.4 pg/ml, P  0.0008; 131  32 versus 0.8  0.7 pg/ml, P  0.01).
Similar trends in TNF-	 levels were seen in lung homogenates
(Figure 5B). BALB/c mice showed a more modest increase in
TNF-	 in response to PA (Figure 5A,B). IFN- levels rose mark-
edly in lung lavage fluid of C57BL/6 mice 24 h after PA challenge
(759  177 pg/ml), and remained very high through Day 7 (Figure
Figure 5. Th1 cytokines in lung la-
vage and lung homogenates after
sensitization and challenge with
PA. TNF-	 (A, B ), IFN- (C, D ), IL-
12p40 (E, F ), IL-12p70 (G, H ) were
measured by ELISA in the superna-
tant obtained from a 1-ml whole
lung lavage (A, C, E, G ) and in 5-ml
lung homogenate protein extracts
(B, D, F, H ) from PA-sensitized/
challenged C57BL/6 (solid bars),
SE-sensitized/challenged C57BL/6
(shaded bars), and PA-sensitized/
challenged BALB/c mice (open
bars). Data represent mean cyto-
kine level  SEM. *P  0.05 versus
respective controls, P  0.05 ver-
sus C57BL/6 PA-exposed mice
(n  3–6 mice per group).
5C). Similar changes were observed in lung homogenates (Figure
5D). In contrast, levels of IFN- rose modestly 1 d after SE
challenge before returning to baseline levels on Day 3. Only a
modest induction of IFN- was also observed in BALB/c mice.
IL-12p40, a subunit of both the IL-12 p35p40 complex as well
as the IL-23 p19p40 heterodimer, was also found to be markedly
higher in PA- versus SE-exposed mice 3–7 d after intratracheal
challenge (Figures 5E and 5F). Despite its lability, the heterodim-
eric 70-kD protein was also detected and significantly higher in
PA-treated animals (Figures 5G and 5H).
In contrast to the observed marked elevations of Th1
cytokines, levels of IL-4 and IL-13 did not increase in lungs of
C57BL/6 mice after challenge with PA (Figures 6A and 6B).
IL-13 levels were very low in the lungs of PA-exposed BALB/c
mice as well (Figure 6B); however, they were  2-fold higher
than IL-13 levels in C57BL/6 mice.
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Figure 6. Th2 cytokines in the lung after sensitization and challenge
with PA. Cytokine levels were measured in lung homogenate protein
extracts by ELISA on the indicated days after challenge. IL-4 (A ) and
IL-13 (B ) levels in C57BL/6 mice sensitized/challenged with PA (solid
bars), C57BL/6 mice sensitized/challenged with SE (shaded bars), and
IL-13 levels (B ) in BALB/c mice sensitized/challenged with PA (open
bars). Data represent mean cytokine level  SEM. *P  0.05 versus
respective controls, P  0.05 versus C57BL/6 PA-exposed mice (n 
3–6 mice per group).
MCP-1 is a C-C chemokine responsible for attracting mono-
cytes and macrophages to sites of inflammation. To evaluate
the contribution of this chemokine to PA-induced pulmonary
inflammation, we measured mRNA and protein levels of MCP-1
in the lungs of PA-treated mice. As shown in Figure 7A, signifi-
cant up-regulation of mRNA expression was found during the
first 7 d after challenge with PA. MCP-1 protein levels in lung
correlated well with these observed changes in gene expression
(Figures 7B and 7C). MCP-1 protein levels were also elevated in
the lungs of SE-exposed C57BL/6 mice and PA-exposed BALB/c
mice, but were significantly lower than PA-exposed C57BL/6
animals. Taken together, these data show that PA potently in-
duces Th1 cytokines and chemokines necessary for granuloma
development in C57BL/6 mice, and provides a mechanistic expla-
nation for the differential pulmonary immune response to these
two gram-positive organisms, as well as the differences observed
in PA-induced pulmonary inflammation between C57BL/6 and
BALB/c mice.
ACE Expression in the Lungs of Mice with
PA-Induced Inflammation
In addition to its constitutive production by the vascular endo-
thelium, ACE can be ectopically secreted by granulomas in sar-
coidosis and other granulomatous diseases. Therefore we mea-
sured ACE mRNA expression in the lungs of PA-challenged
mice. ACE expression was several fold higher than that of con-
trol lungs, 4.5-fold higher 21 d after challenge (Figure E9D).
PA-Induced Changes in TLR Expression
To further examine the mechanisms by which PA induces such
a polarized and robust Th1 cytokine milieu and subsequent gran-
Figure 7. MCP-1 chemokine expression in the lung after sensitization
and challenge with PA. MCP-1 mRNA expression (A ), protein expression
in lung homogenates (B ), and protein levels in lung lavage fluid (C ) in
mice sensitized/challenged with PA (solid bars) and mice sensitized/
challenged with SE (shaded bars). MCP-1 protein levels were also mea-
sured in BALB/c mice sensitized/challenged with PA (B, open bars). Data
in A are expressed as fold-expression over controls, as determined by
quantitative real-time PCR (comparative CT method), whereas data in
B and C are MCP-1 levels as measured by ELISA (n  3–6 mice per
group; *P  0.05 versus respective controls, P  0.05 versus C57BL/6
mice sensitized/challenged with PA).
ulomatous response, we measured changes in TLR expression
in C57BL/6 mice sensitized/challenged with PA and SE. Twenty-
four hours after intratracheal challenge with PA, TLR1, TLR2,
TLR4, TLR5, and TLR9 expression was measured in the lungs,
and compared with TLR expression in the lungs of control (PBS/
PBS) and SE (intraperitoneal SE/intratracheal SE)-treated mice.
TLR5, which is triggered by flagellin, was included as a negative
control, as both PA and SE lack this structure. TLR5 mRNA
expression was not up-regulated in PA-exposed or SE-exposed
mice (data not shown). As shown in Figure 8, significant increases
in TLR1 expression were observed in PA-exposed mice relative
to controls and SE-exposed mice. A trend towards increased
expression of TLR2 ( 40-fold change, P  0.06) and TLR9
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Figure 8. TLR mRNA expression in the
lungs of C57BL/6 mice sensitized and
challenged with PA. TLR1 (A), TLR2 (B),
TLR4 (C), and TLR9 (D) expression was
determined by quantitative real-time PCR
(comparative CT method). Data are ex-
pressed as fold-expression over controls
exposed to PBS. *P  0.05 versus respec-
tive controls, P  0.05 versus C57BL/6
mice sensitized/challenged with SE (n 
3–4 mice per group).
( 30-fold increase, P  0.087) was also observed. A significant
decrease in TLR4 expression was found (P  0.0009). In contrast,
only TLR2 showed up-regulated expression in SE-exposed mice
(Figure 8). Messenger RNA expression was also measured in
livers 1 wk after sensitization, revealing a similar profile but
more modest induction of TLR1, TLR2, and TLR9 in PA- but
not SE-exposed animals (Figure E10). These data show dramatic
differences in TLR expression in response to PA versus SE in
the murine lung, and provide one potential mechanism by which
PA, but not SE, generates a polarized Th1 cytokine storm.
DISCUSSION
PA has long been recognized as a potent immunostimulant capa-
ble of producing granulomatous inflammation in the reticuloen-
dothelial organs of experimental animals after intravenous
injection of heat-killed organisms. Although the mechanisms
of hepatic granuloma formation in response to PA have been
extensively investigated, very little has been published on the
pulmonary immune response to this anaerobic bacterium. With
increasing interest in PA as a putative etiologic agent of sarcoido-
sis, we have characterized the pulmonary immune response to
this organism in mice. In this report we show that sensitization
and challenge with PA can produce granulomatous inflammation
in the lungs of C57BL/6 mice, in concert with an influx of CD4
lymphocytes and elevations of Th1 cytokines, an immunologic
profile similar to what has been reported in humans with
sarcoidosis.
Acute lung inflammation after intratracheal challenge with
PA has been described previously (20). Itakura and colleagues
showed that nonsensitized C57BL/6 mice develop a neutrophilic
alveolitis accompanied by a mild perivascular and peribronchial
accumulation of lymphocytes, peaking 48 h after intratracheal
inoculation. Granulomatous changes were not observed. Based
on these observations, we reasoned that granulomas may take
longer to form and may require sensitization before challenge.
Indeed, by comparing leukocytes in the lavage fluid from sensi-
tized and nonsensitized mice challenged intratracheally with
PA, we found sensitization essential for the lymphocytosis and
increase in macrophage numbers characteristic of animals that
went on to develop pulmonary granulomas.
Pulmonary granulomatosis after intratracheal inoculation
with PA has been described previously in rats. In this study, rats
were sensitized intravenously with heat-killed PA and chal-
lenged 2 wk later intratracheally (21). Histopathology showed
severe intra-alveolar and perivascular granulomatous inflamma-
tion, peaking 48–72 h after intratracheal challenge, with focal
granulomas persisting for 7–14 d. Intravenous challenge with PA
has also been reported to produce granulomatous inflammation
in the lungs of sensitized rabbits and rats (21, 22).
Recently, Nishiwaki and colleagues have reported the devel-
opment of pulmonary granulomas after multiple immunizations
of PA into the footpad of mice (23). The authors propose that PA
is indigenous to the lungs of mice, and that repeated immuniza-
tion of the footpad stimulates an immune response to the same
bacterium residing in the lung. While these results are intriguing,
they may be confounded by the fact that complete Freund’s
adjuvant (CFA), known to contain cell-wall mycobacterial pep-
tides, was required in conjunction with PA to elicit this response.
In our studies, no other adjuvants were employed, ensuring that
the pulmonary immune response elicited was entirely secondary
to PA constituents.
To determine whether the robust pulmonary immune re-
sponse was unique to PA or a general reaction to gram-positive
organisms, we carried out parallel experiments with SE, another
gram-positive commensal of human skin. We observed marked
differences in the pulmonary immune response between these
two bacterial strains. While the initial neutrophilic alveolitis was
similar, the ensuing lymphocytic alveolitis was more severe and
persistent in PA-challenged mice. Proinflammatory cytokines
had largely returned to normal by 48 h in the SE group, but
remained significantly elevated up to 1 wk in the PA-challenged
mice. Granuloma formation was only observed in response to
PA. Recently, the inflammatory response to these same two
organisms has been compared in relation to their roles in the
pathogenesis of acne (24). Cutaneous inflammation was evalu-
ated in vivo by injecting both bacteria into the ears of CBA/J
mice. Only PA was capable of eliciting inflammation in this
model. Together, these findings suggest that PA posseses unique
characteristics rendering them highly immunogenic.
Our data suggest that the mechanism for the differential
effects of these two gram-positive bacteria in the lungs may be
McCaskill, Chason, Hua, et al.: Propionibacterium acnes–Induced Lung Inflammation 355
the capacity of PA to potently induce Th1 cytokines. Analysis
of the genome sequence of PA has revealed several regions
encoding major immune reactive proteins, many of which are
orthologous to proteins found in Mycobacterium tuberculosis
(25). However, the precise molecular mechanisms by which
these “immune reactive” proteins of PA induce such a robust Th1
cytokine storm are poorly understood. It has become increasingly
appreciated that innate immunity contributes substantially to
the adaptive immune response. In this regard, APCs not only
phagocytose bacteria for subsequent killing and presentation
of peptide constituents of pathogens via MHCII to generate an
adaptive immune response, but they also recognize a variety of
molecular structures present in the invading pathogen. TLRs on
the cell surface and within organelles of APCs discriminate these
microorganism-associated molecular structures, and signal the
cell to secrete Th1-inducing cytokines, enhance antigen presenta-
tion, and enhance co-stimulatory molecule expression (26). Thus,
changes in TLR expression or signaling could influence the pul-
monary immune response to PA. Consistent with this paradigm,
we found striking differences in TLR expression in the lungs
of PA- versus SE-exposed mice, which may explain, in part, the
differential immune response elicited by these different gram-
positive bacteria. While only TLR2 expression increased in the
lungs of SE-exposed mice, several fold increases in expression
of TLR1, TLR2, and TLR9 were observed in the lungs of all mice
exposed to PA. TLR1 and 2 act in concert to recognize a variety
of signals including peptidoglycan constituents of the cell wall
of gram-positive bacteria, while TLR9 recognizes unmethylated
CpG motifs of bacterial DNA. TLR9 has been localized to the
endoplasmic reticulum of macrophages and dendritic cells, sug-
gesting that this TLR may be activated by the intracellular persis-
tence and slow degradation characteristic of PA (27). Since mac-
rophage numbers in the lung lavage fluid of PA-exposed mice
were 2-fold higher than SE-exposed animals, differences in TLR
expression could be due, in part, to the number of cells present
in the lungs at the time of analysis. However, nearly all PA-
exposed mice showed more than 20-fold increases in mRNA
expression of TLR2 and TLR9, suggesting that PA up-regulates
the expression of these TLRs. Moreover, expression of some
TLRs (TLR4) was significantly lower in the PA group, despite
potentially greater numbers of macrophages in the lung. To our
knowledge no other studies have examined PA-induced changes
in TLR expression in the lung. Several studies have examined
the role of TLRs in the enhancement of cytokine production
after PA priming by intraperitoneal or intravenous injection,
and suggested roles for TLR2, TLR4, and TLR9 (28–31). Other
intracellular bacterial pathogens have also been shown to in-
crease both TLR2 and TLR9 transcripts in infected organs (32).
Taken together, these studies and ours suggest that both constit-
uents of the bacterial cell wall (activating TLR1 and TLR2)
and bacterial DNA (activating TLR9), coupled with the slow
degradation of PA, may act in concert to produce the immune-
enhancing effects of this bacterium.
While the pulmonary immune response after inoculation with
PA revealed many similarities to the immunobiology of sarcoido-
sis, including (1) noncaseating granulomatous inflammation, (2)
CD4 lymphocytosis, and (3) a highly polarized Th1 cytokine
profile, important differences in histopathology between PA-
induced lung disease in mice and human sarcoidosis merit dis-
cussion. We observed peribronchovascular, and occasional pa-
renchymal and subpleural granulomatous inflammation in the
murine lung—a similar distribution seen in humans with sarcoid-
osis. However, the granulomatous inflammation showed signifi-
cant morphologic differences. In sarcoidosis, well-circumscribed
granulomata composed of a central core of epithelioid histio-
cytes, and multi-nucleated giant cells, are typically surrounded
by a rim of T-, and to a lesser extent, B-lymphocytes. In
PA-induced granulomatous inflammation in the murine lung,
looser collections of epithelioid histiocytes, T-lymphocytes, and
B-lymphocytes was observed. There are several potential rea-
sons for these histopathologic differences. First, it has not been
unequivocally established that PA is etiologically linked to sar-
coidosis. Thus, a triggering antigen other than PA may produce
a different pathologic response. Second, if PA is a triggering
antigen of sarcoidosis, mechanisms of sensitization are undoubt-
edly different than the single sensitization and single challenge
with heat-killed bacteria performed in our studies. In addition,
PA used in these studies may vary phenotypically from PA
present in sarcoid granulomas. Finally, species differences be-
tween mice and humans may explain the pathologic characteris-
tics of the inflammatory response. Indeed, histologic differences
between the most commonly used murine models of asthma
(ovalbumin) and pulmonary fibrosis (bleomycin) are well recog-
nized. Nevertheless, these disease models have still contributed
substantially to our understanding of the pathogenesis of these
two pulmonary disorders.
In contrast to our findings in C57BL/6 mice, BALB/c mice
sensitized and challenged with PA in an identical fashion failed
to develop granulomata in the lung by 1 wk after exposure.
Peribronchovascular chronic inflammation was observed in this
strain, but no histiocytic component was noted in these infiltrates.
A significantly less robust rise in granulomatogenic Th1 cyto-
kines was observed, which may be responsible for the different
pathologic findings. It is well recognized that Th2 cytokines
dampen Th1 immune responses. Although IL-13 levels did not
rise significantly after PA challenge in BALB/c mice, their in-
creased levels relative to the C57BL/6 strain ( 2-fold higher)
could explain, in part, their attenuated Th1 cytokine response
and granuloma formation. These strain differences with PA are
similar to what has been reported in mice exposed to BCG.
BCG-sensitized C57BL/6 mice produce 5- to 10-fold more IFN-
and more TNF from spleen cells in vitro than BALB/c mice
after challenge with BCG extract (33). Our findings in response
to PA coupled with the well-recognized resistance of C57BL/6
and susceptibility of BALB/c mice to infection with Mycobact-
eria spp. is consistent with a model in which granuloma forma-
tion, independent of the stimulus, is significantly influenced by
genetic background of the host (34). For example, MHC presen-
tation of bacterial peptides may vary between strains, as C57Bl/6
mice are of the H-2b haplotype while BALB/c mice are H-2d.
Indeed, combined effects of both background (non–H-2) and
H-2 genes have been shown to contribute to variations in the
immune response to mycobacteria between these two inbred
strains of mice (35). Should propionibacteria be further impli-
cated in human sarcoidosis, then further investigation of inbred,
recombinant inbred, and H-2 congenic strains of mice in this
model could be useful for identifying host genes important to
disease susceptibility, progression, and resolution.
Despite their tendency to incompletely recapitulate the pre-
cise histopathology of human diseases, murine models have sig-
nificantly advanced our understanding of pathogenesis of many
disorders, including those afflicting the lungs. The availability
of numerous inbred strains of mice and the capacity to readily
generate targeted mutations in the mouse genome has made
murine models a powerful tool for dissecting pathophysiologic
pathways, identifying genetic determinants influencing disease
expression, and testing the potential of novel therapies. In this
report we have shown that PA produces granulomatous inflam-
mation in the murine lung, and that the immunologic profile
produced by this exposure shares many features observed
in humans with sarcoidosis. If data continue to implicate PA as
a putative etiologic agent of this disease, mouse models of
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PA-induced pulmonary inflammation may be useful for investi-
gating the mechanisms by which this commensal bacterium may
trigger both self-limited and chronic immune responses in the
lung. Both bacterial and host factors could be tested in such a
model, potentially identifying new paradigms for treating this
enigmatic disease.
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